‘It’s a game-changer’: New drug to protect babies from RSV approved
Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.
Nirsevimab attaches to a protein on the surface of the virus and hinders its ability to enter the body’s cells, especially those in the lungs, according to the European Medicines Agency, a regulatory body that last fall approved the drug for use in the European Union. Palivizumab has to be injected about once a month — up to four times — during RSV season to remain effective. Nirsevimab requires only one dose that lasts the entire RSV season.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Defence Department expecting clarity on cost of new warship fleet later this year | National NewswatchNational Newswatch: Canada's most comprehensive site for political news and views. Make it a daily habit.
Lire la suite »
New Ontario Volkswagen EV battery plant to create 3,000 jobs | National NewswatchNational Newswatch: Canada's most comprehensive site for political news and views. Make it a daily habit.
Lire la suite »
50 Times Restaurant Clients Reached New Heights Of Evil (New Pics)If you thought you had a bad day, just wait and see the awful things restaurant workers have to put up with.
Lire la suite »
SpaceX rocket explodes during 1st test flight after booster fails to separate - National | Globalnews.caSpaceX's giant new rocket blasted off on its first test flight Thursday but exploded minutes after rising from the launch pad and crashed into the Gulf of Mexico.
Lire la suite »
Canadian firms risk falling behind U.S. as AI adoption lags, report warns - National | Globalnews.caA new survey finds Canadian companies are not adopting artificial intelligence as quickly as their U.S. counterparts, and it may be putting them at a competitive disadvantage.
Lire la suite »